ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,424,550 | -5.2% | 7,500 | 0.0% | 0.00% | – |
| Q1 2023 | $1,502,000 | -41.4% | 7,500 | -41.4% | 0.00% | – |
| Q3 2022 | $2,562,000 | -79.1% | 12,800 | -84.8% | 0.00% | -100.0% |
| Q2 2022 | $12,266,000 | +5.4% | 84,100 | +18.0% | 0.00% | +100.0% |
| Q1 2022 | $11,643,000 | -64.3% | 71,300 | -63.0% | 0.00% | -75.0% |
| Q4 2021 | $32,644,000 | +2411.1% | 192,500 | +1825.0% | 0.00% | – |
| Q4 2020 | $1,300,000 | -91.5% | 10,000 | -95.3% | 0.00% | -100.0% |
| Q2 2019 | $15,282,000 | +481.9% | 215,000 | +616.7% | 0.00% | +200.0% |
| Q3 2018 | $2,626,000 | -1.2% | 30,000 | +11.1% | 0.00% | 0.0% |
| Q2 2018 | $2,659,000 | -17.3% | 27,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,216,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 25,300 | $3,690,000 | 0.21% |
| GROUP ONE TRADING, L.P. | 89,600 | $13,068,000 | 0.02% |
| JANE STREET GROUP, LLC | 213,200 | $31,095,000 | 0.01% |
| SIMPLEX TRADING, LLC | 20,100 | $2,931,000 | 0.00% |
| JPMORGAN CHASE & CO | 84,100 | $12,266,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |